{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-033396","form_type":"8-K","ticker":"AIM","cik":"0000946644","company_name":"AIM ImmunoTech Inc.","filed_at":"2023-09-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:37.109813+00:00","generated_at":"2026-06-10T10:00:38.352841+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"medium","headline":"AIM ImmunoTech to present Ampligen oncology data at Roswell Park symposium","bullets":["Chris McAleer, Ph.D., Scientific Officer, will present at the Marie Sklodowska-Curie Symposium on Cancer Research and Care at Roswell Park.","Company also sponsors the symposium; presentation titled 'Rintatolimod (Ampligen): Overview of Ampligen’s Clinical Progress in Oncology'.","No new clinical results or financial data disclosed in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-033396","json":"https://secwatch.observer/filing/0001493152-23-033396.json","markdown":"https://secwatch.observer/filing/0001493152-23-033396.md","text":"https://secwatch.observer/filing/0001493152-23-033396.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/946644/000149315223033396/0001493152-23-033396-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/946644/000149315223033396/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T10:00:38.352841+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}